What is Hepcinat Plus?

Hepcinat plus Natco
is an innovative direct-acting antiviral drug manufactured by Natco Pharma Ltd., an Indian pharmaceutical company. Modern medicine contains two active components - Sofosbuvir (400 mg) and Daclatasvir (60 mg). This drug union of substances is approved for the treatment of chronic hepatitis C by international experts. Natco Pharma Ltd is the first company in India to launch a generic combination of specific doses of sofosbuvir and daclatasvir under the brand name Hepcinat Plus. Today, the patient can get rid of hepatitis C virus by taking just one tablet daily. It is convenient, efficient, and financially beneficial.

What is Myhep Dvir?

Since last year, Myhep Dvir Mylan has been produced, harmoniously combining two nucleotide analogs - Sofosbuvir and Daclatasvir. These drugs were approved by the US Food and Drug Administration, entered the market with noise in 2013, and from that year its Indian generic under the name MyHep began to be released, which is not inferior in treatment efficiency to the original drug, since it is produced according to the identical technology that was provided by Americans from environmentally friendly raw materials. The analogue is attractive in cost and available to most patients today, while the price tag is set on a patented drug of original origin. Sofosbuvirin 2019 it is officially registered in our country, but its purchases at this time are too small. Myhep Dvir is the best option for replacing original anti-HCV products. Often, after a course of therapy, a healthy liver was observed in patients after the examination.